Etvax® is now a registered trademark

Etvax® is now the registered trademark of Scandinavian Biopharma’s vaccine against diarrheal disease caused by enterotoxigenic E. coli bacteria (ETEC). Infections with ETEC bacteria are known to cause debilitating diarrhea in children living in endemic areas, and traveler’s diarrhea in travelers to such risk areas.  Etvax® is presently in Phase I/II clinical trials to document safety and efficacy in the most vulnerable children in which ETEC infection may cause life-threatening disease. Protective efficacy studies of the vaccine in western adults traveling to tropical risk areas are in preparation. There is presently no licensed vaccine against this disease.



Go to MyNewsdesk

We are a research-based specialty biopharma company determined to give people worldwide a longer and better life.